Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CHFS

Nuwellis (CHFS) Stock Price, News & Analysis

Nuwellis logo

About Nuwellis Stock (NASDAQ:CHFS)

Advanced Chart

Key Stats

Today's Range
$0.21
$0.24
50-Day Range
$3.53
$6.02
52-Week Range
$4.86
$37.50
Volume
1.53 million shs
Average Volume
467,323 shs
Market Capitalization
$1.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

CHFS Stock News Headlines

Nuwellis Appoints John L. Erb as CEO
The $100 Trillion AI Story No One Is Telling You
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

CHFS Stock Analysis - Frequently Asked Questions

Nuwellis, Inc. (NASDAQ:CHFS) released its quarterly earnings data on Monday, March, 1st. The company reported ($1.57) earnings per share for the quarter, beating the consensus estimate of ($1.91) by $0.34. The business had revenue of $2.04 million for the quarter. Nuwellis had a negative trailing twelve-month return on equity of 173.61% and a negative net margin of 254.26%.

Nuwellis's stock reverse split before market open on Friday, October 13th 2017.The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuwellis investors own include Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Biocept (BIOC), VBI Vaccines (VBIV), Prima BioMed (IMMP), NightHawk Biosciences (NHWK) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
3/01/2021
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CHFS
Previous Symbol
NASDAQ:SSH
Fax
N/A
Employees
66
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.11 million
Net Margins
-254.26%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.51 million
Price / Cash Flow
N/A
Book Value
$12.79 per share
Price / Book
0.02

Miscellaneous

Free Float
N/A
Market Cap
$1.40 million
Optionable
Not Optionable
Beta
1.55
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:CHFS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners